All Stories

  1. Late Complications After European Medicines Agency-Approved Chimeric Antigen Receptor T-Cell Therapy in Hematological Malignancies: A Scoping Review
  2. Incidence Trends of Early‐Onset Colorectal Cancer in Germany: A Registry‐Based Study From 2003 to 2023
  3. Data from Causes of Death in Patients with Cancer: A Scoping Review
  4. Supplementary Methods 1 from Causes of Death in Patients with Cancer: A Scoping Review
  5. Supplementary Table 1 from Causes of Death in Patients with Cancer: A Scoping Review
  6. Supplementary Table 2 from Causes of Death in Patients with Cancer: A Scoping Review
  7. Development of Psychosocial Distress in Cancer Survivors and Its Potential Prognostic Impact on Survival: A Scoping Review
  8. The development of the European Toolkit for the self-assessment of quality of life across the cancer care continuum (EUonQoL-Kit)
  9. Health-Related Quality of Life in Long-Term Prostate Cancer Survivors Who Received Hormone Therapy: A Scoping Review
  10. The development of the European Toolkit for the self-assessment of quality of life across the cancer care continuum (EUonQoL-Kit)
  11. Causes of Death in Patients with Cancer: A Scoping Review
  12. Data from Beyond GWAS of Colorectal Cancer: Evidence of Interaction with Alcohol Consumption and Putative Causal Variant for the 10q24.2 Region
  13. Supplementary Data from Beyond GWAS of Colorectal Cancer: Evidence of Interaction with Alcohol Consumption and Putative Causal Variant for the 10q24.2 Region
  14. Supplementary Figure from Beyond GWAS of Colorectal Cancer: Evidence of Interaction with Alcohol Consumption and Putative Causal Variant for the 10q24.2 Region
  15. Supplementary Figure from Beyond GWAS of Colorectal Cancer: Evidence of Interaction with Alcohol Consumption and Putative Causal Variant for the 10q24.2 Region
  16. Supplementary Figure from Beyond GWAS of Colorectal Cancer: Evidence of Interaction with Alcohol Consumption and Putative Causal Variant for the 10q24.2 Region
  17. Supplementary Figure from Beyond GWAS of Colorectal Cancer: Evidence of Interaction with Alcohol Consumption and Putative Causal Variant for the 10q24.2 Region
  18. Supplementary Data from A Genetic Locus within the FMN1/GREM1 Gene Region Interacts with Body Mass Index in Colorectal Cancer Risk
  19. Caveats of assessing incidence trends using publicly available registry data
  20. Opportunities and challenges in pooling health-related quality-of-life data for prediction modeling in breast cancer across Europe: lessons from the EORTC BALANCE project
  21. Time-dynamic AI models to predict quality of life in breast cancer patients: Development and validation study using the EORTC BALANCE cohort (Preprint)
  22. Langzeit-Organtoxizität von onkologischen Therapien
  23. Todesursachenspezifische Mortalität in den ersten Jahren nach Diagnose einer Krebserkrankung
  24. Combined lifestyle factors on mortality and cardiovascular disease among cancer survivors: a systematic review and meta-analysis of cohort studies
  25. Combined healthy lifestyle factors and psychosocial outcomes among cancer survivors: a systematic review and meta-analysis
  26. Data from A genetic locus within the FMN1/GREM1 gene region interacts with body mass index in colorectal cancer risk
  27. Data from A genetic locus within the FMN1/GREM1 gene region interacts with body mass index in colorectal cancer risk
  28. Supplementary Data from A genetic locus within the FMN1/GREM1 gene region interacts with body mass index in colorectal cancer risk
  29. Supplementary Data from A genetic locus within the FMN1/GREM1 gene region interacts with body mass index in colorectal cancer risk
  30. Genetic risk impacts the association of menopausal hormone therapy with colorectal cancer risk
  31. Data from A Genetic Locus within the FMN1/GREM1 Gene Region Interacts with Body Mass Index in Colorectal Cancer Risk
  32. Supplementary Data from A Genetic Locus within the FMN1/GREM1 Gene Region Interacts with Body Mass Index in Colorectal Cancer Risk
  33. Supplementary Data from A Genetic Locus within the FMN1/GREM1 Gene Region Interacts with Body Mass Index in Colorectal Cancer Risk
  34. Table 1 from A Genetic Locus within the FMN1/GREM1 Gene Region Interacts with Body Mass Index in Colorectal Cancer Risk
  35. Table 1 from A Genetic Locus within the FMN1/GREM1 Gene Region Interacts with Body Mass Index in Colorectal Cancer Risk
  36. Table 2 from A Genetic Locus within the FMN1/GREM1 Gene Region Interacts with Body Mass Index in Colorectal Cancer Risk
  37. Table 2 from A Genetic Locus within the FMN1/GREM1 Gene Region Interacts with Body Mass Index in Colorectal Cancer Risk
  38. A Genetic Locus within the FMN1/GREM1 Gene Region Interacts with Body Mass Index in Colorectal Cancer Risk
  39. Data from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  40. Data from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  41. Supplementary Figures 1-4 from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  42. Supplementary Figures 1-4 from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  43. Supplementary Tabe 1 from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  44. Supplementary Tabe 1 from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  45. Supplementary Table 2 from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  46. Supplementary Table 2 from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  47. Supplementary Table 3 from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  48. Supplementary Table 3 from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  49. Supplementary Table 4 from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  50. Supplementary Table 4 from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  51. Supplementary Table 5 from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  52. Supplementary Table 5 from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  53. Supplementary Table 6 from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  54. Supplementary Table 6 from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  55. Supplementary Table Legends from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  56. Supplementary Table Legends from Physical Activity and Long-term Quality of Life among Colorectal Cancer Survivors—A Population-based Prospective Study
  57. Persisting Deficits in Health-Related Quality of Life of Colorectal Cancer Survivors 14–24 Years Post-Diagnosis: A Population-Based Study
  58. The preventability of cancer in Europe: A quantitative assessment of avoidable cancer cases across 17 cancer sites and 38 countries in 2020
  59. Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic
  60. Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies
  61. Higher Incidence of Diabetes in Cancer Patients Compared to Cancer-Free Population Controls: A Systematic Review and Meta-Analysis
  62. Correction to: Cancer-Related Fatigue: Causes and Current Treatment Options
  63. Beyond GWAS of Colorectal Cancer: Evidence of Interaction with Alcohol Consumption and Putative Causal Variant for the 10q24.2 Region
  64. The Preventability of Cancer in Europe: A Quantitative Assessment of Avoidable Cancer Cases Across 17 Cancer Sites and 38 Countries in 2020
  65. Potential to Improve Therapy of Chronic Myeloid Leukemia (CML), Especially for Patients with Older Age: Incidence, Mortality, and Survival Rates of Patients with CML in Switzerland from 1995 to 2017
  66. Quality of life, distress, and posttraumatic growth 5 years after colorectal cancer diagnosis according to history of inpatient rehabilitation
  67. Inpatient rehabilitation therapy among colorectal cancer patients – utilization and association with prognosis: a cohort study
  68. Health-Related Quality of Life in Very Long-Term Cancer Survivors 14–24 Years Post-Diagnosis Compared to Population Controls: A Population-Based Study
  69. Correction to: Association of laparoscopic colectomy versus open colectomy on the long‑term health‑related quality of life of colon cancer survivors
  70. Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?
  71. Trends of incidence, mortality and survival for chronic lymphocytic leukaemia / small lymphocytic lymphoma in Switzerland between 1997 and 2016: a population-based study
  72. Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium
  73. Estimation of the Potentially Avoidable Excess Deaths Associated with Socioeconomic Inequalities in Cancer Survival in Germany
  74. The relationship between posttraumatic growth and health-related quality of life in adult cancer survivors: A systematic review
  75. Prevalence and severity of long-term physical, emotional, and cognitive fatigue across 15 different cancer entities
  76. Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk
  77. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk
  78. Health‐related quality of life in long‐term prostate cancer survivors after nerve‐sparing and non‐nerve‐sparing radical prostatectomy—Results from the multiregional PROCAS study
  79. Physical activity and long-term fatigue among colorectal cancer survivors – a population-based prospective study
  80. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
  81. Überleben nach primär metastasiertem Brustkrebs
  82. Physical activity and long-term quality of life among colorectal cancer survivors - a population-based prospective study
  83. Beiträge der Epidemiologie bei der Sekundärprävention von Krebserkrankungen
  84. Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status
  85. Mendelian randomization of circulating polyunsaturated fatty acids and colorectal cancer risk
  86. Development and proof-of-concept of a multicenter, patient-centered cancer registry for breast cancer patients with metastatic disease—the “Breast cancer care for patients with metastatic disease” (BRE-4-MED) registry
  87. Correction to: The relative risk of second primary cancers in Switzerland: a population-based retrospective cohort study
  88. Cancer-Related Fatigue: Causes and Current Treatment Options
  89. Association of laparoscopic colectomy versus open colectomy on the long-term health-related quality of life of colon cancer survivors
  90. The relative risk of second primary cancers in Switzerland: a population-based retrospective cohort study
  91. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis
  92. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
  93. Incidence, mortality, and survival trends of soft tissue and bone sarcoma in Switzerland between 1996 and 2015
  94. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
  95. Age at Diagnosis and Sex Are Associated With Long-term Deficits in Disease-Specific Health-Related Quality of Life of Survivors of Colon and Rectal Cancer: A Population-Based Study
  96. Data from Population-based Cancer Registration for Secondary Data Analysis: Methodological Challenges and Perspectives
  97. World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
  98. Two truncating variants in FANCC and breast cancer risk
  99. Beiträge der Epidemiologie bei der Primärprävention von Krebserkrankungen
  100. Health‐related quality of life in long‐term survivors with localised prostate cancer by therapy—Results from a population‐based study
  101. The association of cancer‐related fatigue with all‐cause mortality of colorectal and endometrial cancer survivors: Results from the population‐based PROFILES registry
  102. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer
  103. Trends of incidence and survival of patients with chronic myelomonocytic leukemia between 1999 and 2014: A comparison between Swiss and American population-based cancer registries
  104. Health-related quality of life in long-term disease-free breast cancer survivors versus female population controls in Germany
  105. Genome-wide association study of germline variants and breast cancer-specific mortality
  106. Return to work after cancer. A multi-regional population-based study from Germany
  107. Age-specific health-related quality of life in long-term and very long-term colorectal cancer survivors versus population controls – a population-based study
  108. Cardiovascular Risk Factors Associated With Venous Thromboembolism
  109. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
  110. Discovery of common and rare genetic risk variants for colorectal cancer
  111. Mendelian randomization analysis of C-reactive protein on colorectal cancer risk
  112. Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis
  113. Correction to: Health-related quality of life among long-term (≥5 years) prostate cancer survivors by primary intervention: a systematic review
  114. The role of psychosocial resources for long-term breast, colorectal, and prostate cancer survivors: prevalence and associations with health-related quality of life
  115. Novel Common Genetic Susceptibility Loci for Colorectal Cancer
  116. “Still a Cancer Patient”—Associations of Cancer Identity With Patient-Reported Outcomes and Health Care Use Among Cancer Survivors
  117. Erratum: Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium
  118. OUP accepted manuscript
  119. Quality of life in long-term and very long-term cancer survivors versus population controls in Germany
  120. Meta-analysis of longitudinal studies: Serum vitamin D and prostate cancer risk
  121. Helicobacter pylori Infection and Gastric Cancer Risk: Evaluation of 15 H. pylori Proteins Determined by Novel Multiplex Serology
  122. Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk
  123. Overweight, obesity and risk of work disability: a cohort study of construction workers in Germany
  124. Quality of life over 5 years in women with breast cancer after breast-conserving therapy versus mastectomy: a population-based study
  125. Timely disclosure of progress in childhood cancer survival by 'period' analysis in the Automated Childhood Cancer Information System
  126. Up-to-date monitoring of childhood cancer long-term survival in Europe: leukaemias and lymphomas
  127. Up-to-date monitoring of childhood cancer long-term survival in Europe: methodology and application to all forms of cancer combined
  128. Body Mass Index and Premature Mortality in Physically Heavily Working Men???A Ten-Year Follow-Up of 20,000 Construction Workers
  129. Recent Major Progress in Long-Term Cancer Patient Survival Disclosed by Modeled Period Analysis
  130. Trends in population-based cancer survival in Germany: to what extent does progress reach older patients?
  131. Up-to-date monitoring of childhood cancer long-term survival in Europe: central nervous system tumours
  132. Up-to-date monitoring of childhood cancer long-term survival in Europe: tumours of the sympathetic nervous system, retinoblastoma, renal and bone tumours, and soft tissue sarcomas
  133. Gender differences in colorectal cancer: implications for age at initiation of screening
  134. Cancer survival in Germany and the United States at the beginning of the 21st century: An up-to-date comparison by period analysis
  135. Restrictions in quality of life in colorectal cancer patients over three years after diagnosis: A population based study
  136. A population-based study of the impact of specific symptoms on quality of life in women with breast cancer 1 year after diagnosis
  137. Construction work and risk of occupational disability: a ten year follow up of 14 474 male workers
  138. Further Enhanced Monitoring of Cancer Patient Survival by Stage-Adjusted Period Analysis
  139. Persistence of Restrictions in Quality of Life From the First to the Third Year After Diagnosis in Women With Breast Cancer
  140. Reduction of clinically manifest colorectal cancer by endoscopic screening: empirical evaluation and comparison of screening at various ages
  141. Period analysis of cancer patient survival in datasets from which the month of diagnosis has been removed
  142. Long-Term Survival Rates of Patients With Prostate Cancer in the Prostate-Specific Antigen Screening Era: Population-Based Estimates for the Year 2000 by Period Analysis
  143. Quality of Life in Patients With Colorectal Cancer 1 Year After Diagnosis Compared With the General Population: A Population-Based Study
  144. Age, alcohol consumption, and all-cause mortality
  145. Recent increase in cancer survival according to age: higher survival in all age groups, but widening age gradient
  146. An alternative approach to age adjustment of cancer survival rates
  147. All-cause and cause specific mortality in a cohort of 20 000 construction workers; results from a 10 year follow up
  148. Epidemiology in aging research
  149. Age-specific detriments to quality of life among breast cancer patients one year after diagnosis
  150. Modification of SAS macros for a more efficient analysis of relative survival rates
  151. Is Helicobacter pylori Infection a Necessary Condition for Noncardia Gastric Cancer?
  152. Provider Delay Among Patients With Breast Cancer in Germany: A Population-Based Study
  153. Interaction between alcohol dehydrogenase II gene, alcohol consumption, and risk for breast cancer
  154. Risk of gastric cancer among smokers infected withHelicobacter pylori
  155. Long-lasting reduction of risk of colorectal cancer following screening endoscopy
  156. Socio-demographic factors, health behavior and late-stage diagnosis of breast cancer in Germany
  157. Environmental Chemical Exposures and Risk of Herpes Zoster
  158. Effects of Short Interpregnancy Intervals on Small-for-Gestational Age and Preterm Births
  159. Elevated liver enzyme activity in construction workers: prevalence and impact on early retirement and all-cause mortality
  160. Early Retirement Due to Permanent Disability in Relation to Smoking in Workers of the Construction Industry
  161. Body weight, pre-existing disease, and all-cause mortality in a cohort of male employees in the German construction industry
  162. Disorders of the Back and Spine in Construction Workers
  163. Chronic respiratory disease morbidity in construction workers: patterns and prognostic significance for permanent disability and overall mortality
  164. Distribution, Determinants, and Prognostic Value of γ-Glutamyltransferase for All-Cause Mortality in a Cohort of Construction Workers from Southern Germany
  165. The association between alcohol consumption and all-cause mortality in a cohort of male employees in the German construction industry.
  166. Smoking patterns and mortality attributable to smoking in a cohort of 3528 construction workers